SAM
RAPP

Sectoral Asset Management’s Rapport Therapeutics RAPP Stock Holding History

Sectoral Asset Management’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,421
Closed -$835K – 89
2026
Q1 		$835K Sell
25,421
-13,504
-35% -$380K 0.69% 37
2025
Q4 		$1.18M Sell
38,925
-4,555
-10% -$126K 0.95% 32
2025
Q3 		$1.29M Sell
43,480
-136,380
-76% -$2.43M 0.8% 44
2025
Q2 		$2.05M Buy
+179,860
New +$1.91M 1.35% 22

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Sectoral Asset Management's RAPP Position: Q2 2026 in Review

Sectoral Asset Management sold out of Rapport Therapeutics (RAPP) in Q2 2026, closing a stake of 25,421 shares — an estimated $835K sold.

Sectoral Asset Management first reported a position in RAPP in Q2 2025 and held it in 4 quarters. The position peaked at $2.05M in Q2 2025. 160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Sectoral Asset Management reported no remaining Rapport Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sectoral Asset Management sold 25,421 Rapport Therapeutics shares in Q2 2026, an estimated $835K.
  • Sectoral Asset Management first reported a position in Rapport Therapeutics in Q2 2025 and held it in 4 quarters.
  • Sectoral Asset Management's Rapport Therapeutics position peaked at $2.05M in Q2 2025.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.